Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $232K | Buy |
659
+27
| +4% | +$9.63K | 0.08% | 144 |
|
|
2025
Q4 | $207K | Buy |
+632
| New | +$200K | 0.07% | 148 |
|
|
2023
Q2 | – | Sell |
-944
| Closed | -$228K | – | 130 |
|
|
2023
Q1 | $228K | Sell |
944
-17
| -2% | -$4.17K | 0.12% | 127 |
|
|
2022
Q4 | $252K | Sell |
961
-1,838
| -66% | -$493K | 0.13% | 121 |
|
|
2022
Q3 | $631K | Buy |
2,799
+1,840
| +192% | +$446K | 0.19% | 113 |
|
|
2022
Q2 | $233K | Buy |
959
+2
| +0.2% | +$490 | 0.11% | 139 |
|
|
2022
Q1 | $231K | Buy |
957
+3
| +0.3% | +$689 | 0.1% | 151 |
|
|
2021
Q4 | $215K | Buy |
+954
| New | +$201K | 0.09% | 165 |
|
|
2021
Q2 | – | Sell |
-803
| Closed | -$200K | – | 166 |
|
|
2021
Q1 | $200K | Sell |
803
-70
| -8% | -$16.7K | 0.1% | 157 |
|
|
2020
Q4 | $201K | Buy |
873
+3
| +0.3% | +$692 | 0.11% | 144 |
|
|
2020
Q3 | $221K | Buy |
870
+3
| +0.3% | +$743 | 0.13% | 121 |
|
|
2020
Q2 | $205K | Buy |
+867
| New | +$198K | 0.12% | 129 |
|
|
2020
Q1 | – | Sell |
-861
| Closed | -$208K | – | 128 |
|
|
2019
Q4 | $208K | Buy |
+861
| New | +$190K | 0.14% | 138 |
|
|
2019
Q3 | – | Sell |
-1,922
| Closed | -$354K | – | 148 |
|
|
2019
Q2 | $354K | Sell |
1,922
-55
| -3% | -$9.85K | 0.25% | 83 |
|
|
2019
Q1 | $376K | Sell |
1,977
-51
| -3% | -$9.74K | 0.27% | 82 |
|
|
2018
Q4 | $395K | Buy |
+2,028
| New | +$396K | 0.33% | 74 |
|
|
2018
Q3 | – | Sell |
-2,008
| Closed | -$371K | – | 125 |
|
|
2018
Q2 | $371K | Sell |
2,008
-1,772
| -47% | -$313K | 0.28% | 78 |
|
|
2018
Q1 | $644K | Buy |
3,780
+30
| +0.8% | +$5.51K | 0.48% | 60 |
|
|
2017
Q4 | $652K | Buy |
3,750
+1,332
| +55% | +$236K | 0.48% | 61 |
|
|
2017
Q3 | $451K | Buy |
2,418
+226
| +10% | +$40K | 0.39% | 68 |
|
|
2017
Q2 | $377K | Buy |
2,192
+11
| +0.5% | +$1.79K | 0.34% | 75 |
|
|
2017
Q1 | $358K | Buy |
2,181
+335
| +18% | +$55.7K | 0.34% | 77 |
|
|
2016
Q4 | $270K | Sell |
1,846
-2,343
| -56% | -$353K | 0.26% | 93 |
|
|
2016
Q3 | $699K | Buy |
+4,189
| New | +$708K | 0.4% | 77 |
|
|
2016
Q2 | – | Sell |
-2,114
| Closed | -$343K | – | 118 |
|
|
2016
Q1 | $343K | Buy |
+2,114
| New | +$314K | 0.22% | 113 |
|
Other funds holding AMGN
VCM
VPM
Investment Partners's AMGN Position: Q1 2026 in Review
Investment Partners increased its Amgen (AMGN) stake by 4.3% in Q1 2026, buying an estimated $9.63K and bringing the position to 659 shares worth $232K. The position accounts for 0.08% of the portfolio, ranked #144.
Investment Partners first reported a position in AMGN in Q1 2016 and has held it in 25 quarters since. The position peaked at $699K in Q3 2016. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Investment Partners held 659 shares of Amgen worth $232K as of Q1 2026.
- Investment Partners bought 27 Amgen shares in Q1 2026, an estimated $9.63K.
- Amgen made up 0.08% of Investment Partners's portfolio in Q1 2026, its #144 holding.
- Investment Partners first reported a position in Amgen in Q1 2016 and has held it in 25 quarters since.
- Investment Partners's Amgen position peaked at $699K in Q3 2016.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.